Reports for LORAZEPAM

Ingredient

LORAZEPAM

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2020-05-08 2020-05-14 114430
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2021-08-27 2021-09-16 144752
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2022-06-30 2023-04-28 163918
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2022-12-08 2023-04-28 177523
APO-LORAZEPAM 0.5MG TABLET Resolved 2017-03-10 2017-08-08 375
APO-LORAZEPAM 0.5MG TABLET Resolved 2021-06-18 2021-09-20 141244
APO-LORAZEPAM 0.5MG TABLET Resolved 2024-04-12 2024-04-26 225014
LORAZEPAM SUBLINGUAL 0.5MG TABLET Resolved 2023-02-03 2023-04-17 183599
LORAZEPAM SUBLINGUAL 0.5MG TABLET Resolved 2023-05-11 2023-07-15 192270
LORAZEPAM 0.5MG TABLET Resolved 2017-08-02 2020-02-27 17964

Showing 71 to 80 of 80

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LORAZEPAM 2MG TABLET Discontinued 2017-06-06 2017-06-07 11983
LORAZEPAM 2MG TABLET Discontinued 2017-06-06 2017-06-07 11986
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
LORAZEPAM 2.0MG TABLET Discontinued 2021-08-12 2022-02-06 144029
LORAZEPAM 2.0MG TABLET Discontinued 2021-12-16 2021-12-17 151293
PMS-LORAZEPAM 1MG TABLET Discontinued 2020-06-15 2021-10-27 117720
APO-LORAZEPAM 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
LORAZEPAM 1MG TABLET Discontinued 2017-06-06 2017-06-07 11980
LORAZEPAM 1.0MG TABLET Discontinued 2021-05-17 2021-11-16 139511
PMS-LORAZEPAM 0.5MG TABLET Discontinued 2020-06-15 2021-10-27 117717

Showing 1 to 10 of 13